Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease ; volume:8 ; number:1 ; day:26 ; month:11 ; year:2018 ; pages:1-8 ; date:12.2018
Scientific reports ; 8, Heft 1 (26.11.2018), 1-8, 12.2018

Creator: Lin, Yung-Shuan
Lee, Wei-Ju
Wang, Shuu-Jiun
Fuh, Jong-Ling

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-018-35766-w

URN: urn:nbn:de:101:1-2019010402032509944827

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lin, Yung-Shuan
Lee, Wei-Ju
Wang, Shuu-Jiun
Fuh, Jong-Ling
SpringerLink (Online service)

Other Objects (12)

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Blood neurofilament light chain in Parkinson’s disease

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer’s disease

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease

Neurofilament light chain Protein im Liquor : Ein Biomarker für Demenz bei Parkinson?

Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease

Related objects

Reset password